eNauka - pregled
Pregled prema Projekat Catalyst Pharmaceuticals, Inc.
Prikaz rezultata 1 do 2 od 2
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2016 | Amifampridine Phosphate in patients with Lambert-Eaton myasthenic syndrome (LEMS): a phase 3, multicentre, double-blind, placebo-controlled trial | Schoser, B; Oh, S; Shcherbakova, N; Kostera-Pruszczyk, A; Alsharabati, M; Dimachkie, M; Blanco, JM; Lavrnic, Dragana V; Shieh, P; Vial, C;
Meisel, Andreas; Brannagan, T; Komoly, S; Sivakumar, K; So, Y;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2022 | Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial | Bonanno, Silvia; Giossi, Riccardo; Zanin, Riccardo; Porcelli, Valentina; Iannacone, Claudio; Baranello, Giovanni; Ingenito, Gary; Iyadurai, Stanley; Stević, Zorica D.  ; Perić, Stojan Z.  ;
Maggi, Lorenzo;
| Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |